speb/financial-data huggingface dataset:
Stock screener scorecard for CGC (quarterly, report date 2026-03-31)
Altman Z-score: -12.756834034215235 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -27.19973503088273%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.8610137156626805%
Free cash flow margin: -24.596764671153622%
Revenue growth: -7.655143931452383%
Rule of 40 score: -32.25190860260601
Market cap: 398462752 (Small Cap ($300M-$2B))
Debt to equity: 0.3995
Free cash flow (dilution adjusted): -14986330.9352518
Operating income: -19765467.62589928
Net income: -113032374.10071944
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CGR.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10250414 (Nano Cap (< $50M))
Debt to equity: 0.0043
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CIB (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.390496709120014%
Capitalized R&D asset: 0
Free cash flow margin: 4.983596019324136%
Revenue growth: 24.317216457003962%
Rule of 40 score: 29.300812476328097
Market cap: 20407183360 (Large Cap ($10B-$200B))
P/E ratio: 8.597839135654262
Debt to equity: 0.4797713468195723
Free cash flow (dilution adjusted): 100240528.50970277
Net income: 404294413.426062
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CTP.AX (annual, report date 2025-06-30)
Altman Z-score: -1.0800244453971506 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 19.638336347197104%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.493888900002%
Free cash flow margin: 13.253564388208867%
Revenue growth: 15.1170485958285%
Rule of 40 score: 28.370612984037365
Market cap: 51187952 (Micro Cap ($50M-$300M))
P/E ratio: 3.2679738562091503
Debt to equity: 0.6801999999999999
Free cash flow (dilution adjusted): 3779084.9673202615
Operating income: 6857516.339869281
Net income: 5054901.960784313
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CTP.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 51187952 (Micro Cap ($50M-$300M))
P/E ratio: 3.2679738562091503
Debt to equity: 0.6801999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DK (quarterly, report date 2026-03-31)
Altman Z-score: 0.36006855323018766 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.399676097465218%
Free cash flow margin: 9.80362594700539%
Revenue growth: 9.208034905738042%
Rule of 40 score: 19.011660852743432
Market cap: 3873372928 (Mid Cap ($2B-$10B))
P/E ratio: 252.00987453577983
Debt to equity: 11.255
Free cash flow (dilution adjusted): 260100000
Operating income: -179300000
Net income: -190900000
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for DVL.NS (annual, report date 2026-03-31)
Altman Z-score: 0.5270635919418025 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.36925438073369%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.864659413237161%
Free cash flow margin: -221.2196180216977%
Revenue growth: -20.166228844107785%
Rule of 40 score: -241.3858468658055
Market cap: 8544988672 (Mid Cap ($2B-$10B))
P/E ratio: 0.07861251985869128
Debt to equity: 0.2895
Free cash flow (dilution adjusted): -87154832.55616787
Operating income: -9277214.92157694
Net income: 9641119.118270453
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DVL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.479357306110863 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.9311909893330867%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.4251598468769036%
Revenue growth: -5.827216416081759%
Rule of 40 score: -5.827216416081759
Market cap: 8544988672 (Mid Cap ($2B-$10B))
P/E ratio: 0.07861251985869128
Debt to equity: 0.2895
Operating income: -7090578.635014837
Net income: 2581083.0860534124
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for ECK.DE (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.5117056856187294%
Capitalized R&D asset: 0
Free cash flow margin: -20.666666666666668%
Revenue growth: -34.56635971874312%
Rule of 40 score: -55.23302638540979
Market cap: 85724000 (Micro Cap ($50M-$300M))
Debt to equity: 1.2074
Free cash flow (dilution adjusted): -3563218.3908045976
Net income: -2413793.103448276
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for FIH.L (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 19092848 (Nano Cap (< $50M))
Debt to equity: 0.6584
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HCH.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.827968566724136%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.003871086941522%
Rule of 40 score: 0
Market cap: 291108672 (Micro Cap ($50M-$300M))
Debt to equity: 0.0014000000000000002
Free cash flow (dilution adjusted): -20240617.647058822
Operating income: -7848103.9215686275
Net income: -7279442.483660131
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for HCH.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 291108672 (Micro Cap ($50M-$300M))
Debt to equity: 0.0014000000000000002
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for HTO (quarterly, report date 2026-03-31)
Altman Z-score: 0.7021018638762287 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.515753602174263%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7206654168406103%
Free cash flow margin: -27.51769025549257%
Revenue growth: -5.609570205885079%
Rule of 40 score: -33.12726046137765
Market cap: 2671081472 (Mid Cap ($2B-$10B))
P/E ratio: 19.938356164383563
Debt to equity: 1.0218
Free cash flow (dilution adjusted): -50438000
Operating income: 37426000
Net income: 19013000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for IQ.V (quarterly, report date 2025-12-31)
Altman Z-score: -5.380146683591408 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 6.41614702986544%
Capitalized R&D asset: 52549.59827758232
ROCI (R&D adjusted): 1.435681119948585%
Rosenberg metric: 4.342457420924569
Free cash flow margin: -43.41720304271504%
Revenue growth: 13.47833148622308%
Rule of 40 score: -29.938871556491957
Market cap: 13734740 (Nano Cap (< $50M))
P/E ratio: 36.496350364963504
Debt to equity: 0
Free cash flow (dilution adjusted): -541605.8394160583
Operating income: 86131.38686131386
Net income: 75182.48175182482
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for IVR.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 101457560 (Micro Cap ($50M-$300M))
Debt to equity: 0.0025
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KKO.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 53765856 (Micro Cap ($50M-$300M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KKO.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.131661391966697%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.130535767555038%
Rule of 40 score: 0
Market cap: 53765856 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3571769.934640523
Operating income: -3820756.209150327
Net income: -3622386.274509804
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for LEG.AX (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 23315820 (Nano Cap (< $50M))
Debt to equity: 0.003
Free cash flow (dilution adjusted): -1315353.6912751677
Operating income: -10568243.624161074
Net income: -10028365.10067114
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MAT (quarterly, report date 2026-03-31)
Altman Z-score: 1.8289264718507299 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 121.17247660842925%
Capitalized R&D asset: 59937000
ROCI (R&D adjusted): -0.7378904577817177%
Free cash flow margin: -11.71844100532261%
Revenue growth: -51.19215832795535%
Rule of 40 score: -62.91059933327796
Market cap: 4166759424 (Mid Cap ($2B-$10B))
P/E ratio: 9.314102564102564
Debt to equity: 1.2702
Free cash flow (dilution adjusted): -101033000
Operating income: -78173000
Net income: 61030000
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MDRR (quarterly, report date 2026-03-31)
Altman Z-score: 0.34153626147849786 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 69.02087822402808%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3039120768873339%
Free cash flow margin: -48.78479482601718%
Revenue growth: -23.526968044641453%
Rule of 40 score: -72.31176287065864
Market cap: 18141490 (Nano Cap (< $50M))
P/E ratio: 3.0433604336043363
Debt to equity: 0.4813
Free cash flow (dilution adjusted): -1053393
Operating income: -181853
Net income: 14122769
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MNTN.L (annual, report date 2026-01-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 24.451475242607078%
Capitalized R&D asset: 0
Free cash flow margin: -3.6156910165918257%
Revenue growth: 213.51714002747516%
Rule of 40 score: 209.90144901088334
Market cap: 2011144064 (Mid Cap ($2B-$10B))
P/E ratio: 0.05749354005167959
Debt to equity: 0
Free cash flow (dilution adjusted): -22176388.888888888
Net income: 609897222.2222222
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MNTN.L (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2011144064 (Mid Cap ($2B-$10B))
P/E ratio: 0.05749354005167959
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MP1.AX (annual, report date 2025-06-30)
Altman Z-score: 32.77920065460807 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.2467603469420926%
Free cash flow margin: 14.951114242931386%
Revenue growth: 13.999438286921698%
Rule of 40 score: 28.950552529853084
Market cap: 4476546560 (Mid Cap ($2B-$10B))
Debt to equity: 0.184
Free cash flow (dilution adjusted): 22188235.29411765
Operating income: -327450.98039215687
Net income: -190849.6732026144
Long score: 7 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MP1.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4476546560 (Mid Cap ($2B-$10B))
Debt to equity: 0.184
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MXI.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 83348936 (Micro Cap ($50M-$300M))
P/E ratio: 9.027777777777777
Debt to equity: 0.5343
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MYPS (quarterly, report date 2026-03-31)
Altman Z-score: 0.8908609498208367 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.9522213259865285%
Capitalized R&D asset: 30114200
ROCI (R&D adjusted): -3.3519909577315663%
Rosenberg metric: 0.28448385861936965
Free cash flow margin: -4.6875535011128235%
Revenue growth: 5.4294068806180285%
Rule of 40 score: 0.7418533795052049
Market cap: 79267024 (Micro Cap ($50M-$300M))
Debt to equity: 0.0315
Free cash flow (dilution adjusted): -2738000
Operating income: -8653000
Net income: -10676000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for NACON.PA (quarterly, report date 2025-09-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 23096324 (Nano Cap (< $50M))
Debt to equity: 0.4999
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NPFD (quarterly, report date 2026-01-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 441237216 (Small Cap ($300M-$2B))
P/E ratio: 8.669767441860465
Debt to equity: 0.5589
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NTWO (quarterly, report date 2026-03-31)
Altman Z-score: 25.16704842709745 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.7790296783813334%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.1191145366141236%
Rule of 40 score: 0
Market cap: 259009872 (Micro Cap ($50M-$300M))
P/E ratio: 40.42307692307692
Debt to equity: 0
Free cash flow (dilution adjusted): -275113
Operating income: -219150
Net income: 1386245
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for NUC.AX (annual, report date 2025-06-30)
Altman Z-score: -5.914363686600268 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -46.690138123237126%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -35.032042284961285%
Free cash flow margin: -17.2555887072742%
Revenue growth: 98.24079247079243%
Rule of 40 score: 80.98520376351823
Market cap: 13329595 (Nano Cap (< $50M))
Debt to equity: 0.0305
Free cash flow (dilution adjusted): -2587171.2418300654
Operating income: -2746379.0849673203
Net income: -2498824.836601307
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for NUC.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13329595 (Nano Cap (< $50M))
Debt to equity: 0.0305
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NUV (annual, report date 2025-10-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.1299090418507274%
Capitalized R&D asset: 0
Revenue growth: -69.70357366035678%
Rule of 40 score: -69.70357366035678
Market cap: 1884477696 (Small Cap ($300M-$2B))
P/E ratio: 17.137254901960784
Debt to equity: 0.0633
Net income: 59761530
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NUV (quarterly, report date 2025-10-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1884477696 (Small Cap ($300M-$2B))
P/E ratio: 17.137254901960784
Debt to equity: 0.0633
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PHARM.AS (quarterly, report date 2026-03-31)
Altman Z-score: 2.067301553065402 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.692372365407474%
Capitalized R&D asset: 63756709.12778904
ROCI (R&D adjusted): -1.6601261310673223%
Rosenberg metric: -0.6576234468435564
Free cash flow margin: -2.0856626223308075%
Revenue growth: -33.53844908531651%
Rule of 40 score: -35.624111707647316
Market cap: 848915264 (Small Cap ($300M-$2B))
P/E ratio: 82.183908045977
Debt to equity: 0.4321
Free cash flow (dilution adjusted): -1736781.6091954021
Operating income: -6078160.91954023
Net income: -5991954.022988506
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for PREVA.AS (annual, report date 2025-12-31)
Altman Z-score: 1.9529510624782764 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 14.269289514761912%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.077560845145763%
Free cash flow margin: -406.5528058556988%
Revenue growth: -39.80526931188601%
Rule of 40 score: -446.35807516758484
Market cap: 47483372.800000004 (Nano Cap (< $50M))
P/E ratio: 3.007234979553319
Debt to equity: 0.1557
Free cash flow (dilution adjusted): -13722352.94117647
Operating income: 21223529.411764707
Net income: 19852941.17647059
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for PREVA.AS (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 47483372.800000004 (Nano Cap (< $50M))
P/E ratio: 3.007234979553319
Debt to equity: 0.1557
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RDI (quarterly, report date 2026-03-31)
Altman Z-score: -0.5408819808765243 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.2085275728626996%
Free cash flow margin: -6.280471589398102%
Revenue growth: -10.240292807129217%
Rule of 40 score: -16.52076439652732
Market cap: 50713428 (Micro Cap ($50M-$300M))
Debt to equity: -14.269232284239965
Free cash flow (dilution adjusted): -2834000
Operating income: -3632000
Net income: -8134000
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for RELIABLE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.6142417436887033 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.4204916575559348%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.156920675044151%
Revenue growth: 123.18180075678305%
Rule of 40 score: 123.18180075678305
Market cap: 1484841600 (Small Cap ($300M-$2B))
P/E ratio: 0.17554045738445037
Debt to equity: 0.2876
Operating income: 242168.2916490038
Net income: 135894.4467994913
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for RELIABLE.NS (annual, report date 2026-03-31)
Altman Z-score: 2.528443843388949 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.779486224713347%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.817589130728216%
Free cash flow margin: 14.479810371535848%
Revenue growth: 28.480767779357436%
Rule of 40 score: 42.960578150893284
Market cap: 1484841600 (Small Cap ($300M-$2B))
P/E ratio: 0.17554045738445037
Debt to equity: 0.2876
Free cash flow (dilution adjusted): 2840069.9448919035
Operating income: 1439094.9554896143
Net income: 729196.693514201
Long score: 10 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for RIO.MC (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4818974 (Nano Cap (< $50M))
Debt to equity: 1.841
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RIO.MC (annual, report date 2025-12-31)
Altman Z-score: 0.2181589852392084 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -23.37506559712122%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -17.87767903815996%
Free cash flow margin: 13.093313739897134%
Revenue growth: -4.484595055943215%
Rule of 40 score: 8.608718683953919
Market cap: 4818974 (Nano Cap (< $50M))
Debt to equity: 1.841
Free cash flow (dilution adjusted): 2096470.5882352942
Operating income: -3218823.529411765
Net income: -5335294.117647059
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for RUBFILA.NS (annual, report date 2026-03-31)
Altman Z-score: 5.796715634820108 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.333195574052609%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.59848647813348%
Free cash flow margin: -4.676716797820281%
Revenue growth: -0.7685010577353809%
Rule of 40 score: -5.445217855555661
Market cap: 3965871104 (Mid Cap ($2B-$10B))
P/E ratio: 0.12625240328445028
Debt to equity: 0.0033
Free cash flow (dilution adjusted): -2986138.1941500637
Operating income: 3113533.2768122084
Net income: 2820252.225519288
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RUBFILA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.448063640869513 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.5346782083114047%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.4010484667081675%
Free cash flow margin: -16.25727046923909%
Revenue growth: 4.124348290007711%
Rule of 40 score: -12.132922179231379
Market cap: 3965871104 (Mid Cap ($2B-$10B))
P/E ratio: 0.12625240328445028
Debt to equity: 0.0033
Free cash flow (dilution adjusted): -2766945.7397202207
Operating income: 869425.604069521
Net income: 680203.4760491734
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SGZ.V (quarterly, report date 2026-03-31)
Altman Z-score: 11.012064115148675 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.1380507414252505%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.1393303890990731%
Rule of 40 score: 0
Market cap: 7490571 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): 157974.82014388492
Operating income: -62772.6618705036
Net income: -62772.6618705036
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SMN.AX (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 498709.18322295806
Rule of 40 score: 0
Market cap: 58352544 (Micro Cap ($50M-$300M))
P/E ratio: 13.398692810457515
Debt to equity: 0.2895
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SNG.DE (annual, report date 2025-12-31)
Altman Z-score: -3.79369737695572 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 12938823.529411765
Rosenberg metric: -2.018382352941176
Free cash flow margin: -9.128630705394192%
Revenue growth: -28.182523669098252%
Rule of 40 score: -37.311154374492446
Market cap: 71706016 (Micro Cap ($50M-$300M))
Debt to equity: -0.5718701700154559
Free cash flow (dilution adjusted): -5176470.588235294
Operating income: -14470588.235294119
Net income: -16705882.352941178
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SNG.V (quarterly, report date 2026-03-31)
Altman Z-score: 60.094775144823856 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.3383391157316524%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.114255552766023%
Rule of 40 score: 0
Market cap: 11839815 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -88073.38129496404
Operating income: -80457.55395683454
Net income: -49310.07194244605
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for SWLF.V (quarterly, report date 2025-12-31)
Altman Z-score: 5.067314705724039 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.1143758625856997%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.6258876569326244%
Rule of 40 score: 0
Market cap: 5595956 (Nano Cap (< $50M))
Debt to equity: 0.0031
Free cash flow (dilution adjusted): -243910.21897810217
Operating income: -57470.07299270073
Net income: -40148.905109489046
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for SWLF.V (annual, report date 2025-12-31)
Altman Z-score: 4.98402549783231 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.081753461312696%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.4116869632447875%
Rule of 40 score: 0
Market cap: 5595956 (Nano Cap (< $50M))
Debt to equity: 0.0031
Free cash flow (dilution adjusted): -349661.3138686131
Operating income: -155939.41605839416
Net income: -147345.25547445254
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for TRIN (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 2.5223471710732217%
Capitalized R&D asset: 0
Free cash flow margin: -89.89857696275965%
Revenue growth: -12.763861764456145%
Rule of 40 score: -102.6624387272158
Market cap: 1551460864 (Small Cap ($300M-$2B))
P/E ratio: 7.544973544973545
Debt to equity: 1.1643999999999999
Free cash flow (dilution adjusted): -46180000
Net income: 29832000
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for TT.V (quarterly, report date 2026-01-31)
Altman Z-score: 7.080238955548742 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.706485462885544%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.757044292089168%
Rule of 40 score: 0
Market cap: 12055658 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -1722483.7037037036
Operating income: -1089133.3333333333
Net income: -1059906.6666666665
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for TWEKA.AS (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1706238208 (Small Cap ($300M-$2B))
P/E ratio: 17.652022834450236
Debt to equity: 0.7506
Long score: 1 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VRCA (quarterly, report date 2026-03-31)
Altman Z-score: -9.944027339744077 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -59.09685456244161%
Capitalized R&D asset: 6276050
ROCI (R&D adjusted): -30.22102956055849%
Rosenberg metric: 0.1757936507936508
Free cash flow margin: -200.27871789767073%
Revenue growth: -1.3550667714061273%
Rule of 40 score: -201.63378466907685
Market cap: 86237512 (Micro Cap ($50M-$300M))
Debt to equity: 0.0898
Free cash flow (dilution adjusted): -10060000
Operating income: -9715000
Net income: -9682000
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for WELL (quarterly, report date 2026-03-31)
Altman Z-score: 4.816868645018111 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.142198045722356%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8602505547676683%
Free cash flow margin: 19.443131897551563%
Revenue growth: 5.467007960509797%
Rule of 40 score: 24.91013985806136
Market cap: 177939857408 (Large Cap ($10B-$200B))
P/E ratio: 95.18840579710145
Debt to equity: 0.4449
Free cash flow (dilution adjusted): 642732000
Operating income: 558424000
Net income: 752324000
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ZIM.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1428351616 (Small Cap ($300M-$2B))
P/E ratio: 4.221132897603486
Debt to equity: 0.0365
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0948.HK (annual, report date 2025-03-31)
Altman Z-score: -12.18260486577767 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -46.63869693978282%
Revenue growth: -57.65713704594124%
Rule of 40 score: -104.29583398572406
Market cap: 94824488.09 (Micro Cap ($50M-$300M))
Debt to equity: -1.0690883409586391
Free cash flow (dilution adjusted): -2429048.8431876604
Operating income: -6285604.1131105395
Net income: -25355784.061696656
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 148A.T (annual, report date 2025-12-31)
Altman Z-score: 3.0495980671226572 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 25.263687838968586%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.362904113281814%
Free cash flow margin: 9.651916912354967%
Revenue growth: 16.978245918533062%
Rule of 40 score: 26.63016283088803
Market cap: 4064781796.718159 (Mid Cap ($2B-$10B))
P/E ratio: 16.460804969357202
Debt to equity: 0.431446547000978
Free cash flow (dilution adjusted): 1702710.8241161052
Operating income: 1676005.3705006074
Net income: 1578780.1291477527
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1855.HK (annual, report date 2024-12-31)
Altman Z-score: 1.59489396261312 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.424406374416284%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.82978958626542%
Free cash flow margin: -2.4241405502406064%
Revenue growth: -27.92502592638434%
Rule of 40 score: -30.349166476624944
Market cap: 5324014175.257732 (Mid Cap ($2B-$10B))
P/E ratio: 115.51844678132557
Debt to equity: 1.1214235052666528
Free cash flow (dilution adjusted): -5788356.164383561
Operating income: 27381917.80821918
Net income: 6313424.657534246
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 4976.T (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 5130124742.46 (Mid Cap ($2B-$10B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 7063.T (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 10520637504 (Large Cap ($10B-$200B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8475.HK (annual, report date 2025-08-31)
Altman Z-score: -239.83956888231432 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -156.75596971461852%
Revenue growth: 6.428326212999705%
Rule of 40 score: -150.3276435016188
Market cap: 783971.2451861361 (Nano Cap (< $50M))
Debt to equity: -0.8340960569500301
Free cash flow (dilution adjusted): -4205468.75
Operating income: -6458593.75
Net income: -1338281.25
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 8631.HK (annual, report date 2025-03-31)
Altman Z-score: -3.7338484573663853 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -21.272838660852642%
Revenue growth: -19.088725589354475%
Rule of 40 score: -40.36156425020712
Market cap: 25440000 (Nano Cap (< $50M))
Debt to equity: -0.7635266221168356
Free cash flow (dilution adjusted): -1517480.7197943444
Operating income: -4401285.347043701
Net income: -4957969.151670951
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 8929.T (annual, report date 2025-12-31)
Altman Z-score: 4.751485273881772 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 39.85102420856611%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.08695222079335%
Free cash flow margin: 1.8403733397152087%
Revenue growth: -8.062722491095847%
Rule of 40 score: -6.222349151380639
Market cap: 37448957190.69729 (Large Cap ($10B-$200B))
P/E ratio: 13.539030076174004
Debt to equity: 0.5304867634500426
Free cash flow (dilution adjusted): 4916565.43699252
Operating income: 24672335.5284189
Net income: 17684291.285723418
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 8944.T (annual, report date 2025-09-30)
Altman Z-score: 1.2903313748233034 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -12.872326553688445%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.293920828579453%
Free cash flow margin: 2.842191287252976%
Revenue growth: 79.18997512486297%
Rule of 40 score: 82.03216641211594
Market cap: 4743221485 (Mid Cap ($2B-$10B))
Debt to equity: 2.0806702019597076
Free cash flow (dilution adjusted): 3558115.746971736
Operating income: 4273297.442799462
Net income: -2411769.851951548
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AXE.V (annual, report date 2025-12-31)
Altman Z-score: -202.17713154860382 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1540197.3310703894
Free cash flow margin: -188.28225917464678%
Revenue growth: 36.75135651373744%
Rule of 40 score: -151.53090266090933
Market cap: 11450307.92 (Nano Cap (< $50M))
Debt to equity: -0.5482551122528001
Free cash flow (dilution adjusted): -988389.7810218977
Operating income: -1300156.9343065692
Net income: -1357944.525547445
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for BBSE3.SA (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 86.86417558031627%
Capitalized R&D asset: 0
Free cash flow margin: 60.470621287369106%
Revenue growth: 24.926824748867496%
Rule of 40 score: 85.3974460362366
Market cap: 64267524957.035545 (Large Cap ($10B-$200B))
P/E ratio: 7.1271132457333595
Debt to equity: 0
Free cash flow (dilution adjusted): 677147810.218978
Net income: 1645497992.7007298
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for BIRD (annual, report date 2025-12-31)
Altman Z-score: -7.3971126920239465 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -202.0396774463573%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -109.30252846154964%
Free cash flow margin: -43.28243673999449%
Revenue growth: -19.651975948186365%
Rule of 40 score: -62.934412688180856
Market cap: 25726790.7 (Nano Cap (< $50M))
Debt to equity: 1.1037478420671605
Free cash flow (dilution adjusted): -65991000
Operating income: -75175000
Net income: -77283000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BRAG (annual, report date 2025-12-31)
Altman Z-score: 0.8975520220112883 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.325106893706399%
Free cash flow margin: 1.5960555838376984%
Revenue growth: 8.547540359737402%
Rule of 40 score: 10.1435959435751
Market cap: 75905053.30800001 (Micro Cap ($50M-$300M))
Debt to equity: 0.12127204873847726
Free cash flow (dilution adjusted): 1235766.4233576641
Operating income: -3077372.2627737224
Net income: -5923357.6642335765
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for CIB (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.731347091376724%
Capitalized R&D asset: 0
Free cash flow margin: 36.42388846147677%
Revenue growth: 23.630932870316585%
Rule of 40 score: 60.054821331793356
Market cap: 25293557003241.04 (Mega Cap (>= $200B))
P/E ratio: 6.41691742653131
Debt to equity: 0.44129479739232713
Free cash flow (dilution adjusted): 2677404116.0712852
Net income: 1053800602.0649867
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for FIH.L (annual, report date 2025-03-31)
Altman Z-score: 0.7684806949362109 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.808580464228175%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -9.687122894769058%
Free cash flow margin: 6.298653610771114%
Revenue growth: -20.10857994464552%
Rule of 40 score: -13.809926333874404
Market cap: 204074.37 (Nano Cap (< $50M))
Debt to equity: 0.4486976695138669
Free cash flow (dilution adjusted): 3341558.441558441
Operating income: -7193506.493506493
Net income: -6663636.363636363
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for HTO (annual, report date 2025-12-31)
Altman Z-score: 0.7432847606405631 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -34.88888139009096%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.6406922784765476%
Free cash flow margin: -35.54166302352015%
Revenue growth: 6.967969333506137%
Rule of 40 score: -28.573693690014014
Market cap: 2017118307.8700001 (Mid Cap ($2B-$10B))
P/E ratio: 19.66423899734836
Debt to equity: 1.2832257356868737
Free cash flow (dilution adjusted): -284543000
Operating income: 177527000
Net income: 102578000
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for IQ.V (annual, report date 2025-03-31)
Altman Z-score: -7.082133055045465 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 9.106984969053933%
Capitalized R&D asset: 171292.87749287748
ROCI (R&D adjusted): 1.2466366297246838%
Rosenberg metric: -1.4367574173399436
Free cash flow margin: -0.6676290147961026%
Revenue growth: -5.11501556115265%
Rule of 40 score: -5.782644575948753
Market cap: 10042605.160000002 (Nano Cap (< $50M))
P/E ratio: 49.47096137931035
Debt to equity: 0
Free cash flow (dilution adjusted): -25874.12587412588
Operating income: 65034.96503496504
Net income: 141958.04195804195
Long score: 4 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for LEG.AX (quarterly, report date 2024-12-31)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 29144771.85 (Nano Cap (< $50M))
Debt to equity: 0.0015138883644000025
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MDRR (annual, report date 2025-12-31)
Altman Z-score: -0.08315002152640902 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.823171415305401%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.7246820016543045%
Free cash flow margin: -6.330106578889404%
Revenue growth: 6.794888243368577%
Rule of 40 score: 0.46478166447917335
Market cap: 19802560 (Nano Cap (< $50M))
Debt to equity: 1.3615199568080885
Free cash flow (dilution adjusted): -658117
Operating income: 995586
Net income: -1935773
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for MYPS (annual, report date 2025-12-31)
Altman Z-score: 1.3639112605395587 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 126921950
ROCI (R&D adjusted): -7.350195000676039%
Rosenberg metric: -0.5774418982610109
Free cash flow margin: -1.8273308464165854%
Revenue growth: -18.772134098518116%
Rule of 40 score: -20.599464944934702
Market cap: 72971767.05 (Micro Cap ($50M-$300M))
Debt to equity: 0.033905892059368226
Free cash flow (dilution adjusted): -4296000
Operating income: -20440000
Net income: -28639000
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for NACON.PA (annual, report date 2025-03-31)
Altman Z-score: 0.4606064749705794 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 782686.8863955119
ROCI (R&D adjusted): -0.5881256335244255%
Rosenberg metric: 17.450458444247264
Free cash flow margin: -9.11137045681894%
Revenue growth: 1.2231711926385715%
Rule of 40 score: -7.888199264180369
Market cap: 65366959.199999996 (Micro Cap ($50M-$300M))
Debt to equity: 0.5263589144860618
Free cash flow (dilution adjusted): -16632608.695652174
Operating income: -2477173.913043478
Net income: -1459782.608695652
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for NPFD (annual, report date 2025-07-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 428671861.34 (Small Cap ($300M-$2B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NTWO (annual, report date 2025-12-31)
Altman Z-score: 18.163347631401844 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.750020170329962%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.3770349456681598%
Rule of 40 score: 0
Market cap: 187723051.25 (Micro Cap ($50M-$300M))
P/E ratio: 28.352707758897758
Debt to equity: 0
Free cash flow (dilution adjusted): -464695
Operating income: -688452
Net income: 6620992
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for RDI (annual, report date 2025-12-31)
Altman Z-score: -0.25388384492395566 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.7323436092287203%
Free cash flow margin: -1.7202987368711449%
Revenue growth: -3.5810133617065745%
Rule of 40 score: -5.30131209857772
Market cap: 22088503.5 (Nano Cap (< $50M))
Debt to equity: -19.945076804066748
Free cash flow (dilution adjusted): -3492000
Operating income: -5307000
Net income: -14140000
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for SGZ.V (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4280326.32 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SNG.DE (quarterly, report date 2025-06-30)
Altman Z-score: -2.550561608612666 (Distress Zone)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 1411764.705882353
Rule of 40 score: 0
Market cap: 17170297.109999996 (Nano Cap (< $50M))
Debt to equity: -0.6634429400386848
Operating income: -2117647.0588235296
Net income: -2117647.0588235296
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for SNG.V (annual, report date 2025-12-31)
Altman Z-score: 69.74484105533996 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -15.881655091504568%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -13.33533877560229%
Rule of 40 score: 0
Market cap: 13813118.06 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -691782.4817518247
Operating income: -517728.46715328464
Net income: -552922.6277372262
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for TRIN (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.323503037936963%
Capitalized R&D asset: 0
Free cash flow margin: -262.0954577888121%
Revenue growth: 16.593159880109862%
Rule of 40 score: -245.50229790870225
Market cap: 1235056324.74 (Small Cap ($300M-$2B))
P/E ratio: 9.107816323559778
Debt to equity: 1.182995596888114
Free cash flow (dilution adjusted): -536284000
Net income: 135604000
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for VRCA (annual, report date 2025-12-31)
Altman Z-score: -5.242000763740837 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -69.1306632178798%
Capitalized R&D asset: 23485150
ROCI (R&D adjusted): -30.911030042614797%
Rosenberg metric: 2.3065878378378377
Free cash flow margin: -58.872305140961856%
Revenue growth: 370.2220459952419%
Rule of 40 score: 311.34974085428007
Market cap: 142755711.66 (Micro Cap ($50M-$300M))
Debt to equity: 0.06591763327001576
Free cash flow (dilution adjusted): -20945000
Operating income: -11939000
Net income: -17886000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for WELL (annual, report date 2025-12-31)
Altman Z-score: 3.368275536457643 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.27890467624371%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.542677285356991%
Free cash flow margin: 12.10396117570827%
Revenue growth: 35.824482423260214%
Rule of 40 score: 47.928443598968485
Market cap: 130114151424 (Large Cap ($10B-$200B))
P/E ratio: 135.27671676593852
Debt to equity: 0.4948805681946777
Free cash flow (dilution adjusted): 1291146000
Operating income: 355168000
Net income: 961837000
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 0182.HK (annual, report date 2025-12-31)
Altman Z-score: 0.471201011202803 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.252093088822967%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.903706654489645%
Free cash flow margin: -30.338615868580447%
Revenue growth: 0.11164888682367825%
Rule of 40 score: -30.226966981756767
Market cap: 2770845696 (Mid Cap ($2B-$10B))
P/E ratio: 2.056555269922879
Debt to equity: 2.1908000000000003
Free cash flow (dilution adjusted): -546934375
Operating income: 601360937.5
Net income: 122370312.5
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for 0182.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2770845696 (Mid Cap ($2B-$10B))
P/E ratio: 2.056555269922879
Debt to equity: 2.1908000000000003
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0277.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 321590144 (Small Cap ($300M-$2B))
Debt to equity: 0.0154
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0277.HK (annual, report date 2026-03-31)
Altman Z-score: 3.334341236231331 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.010684526751814%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.04384869318596688%
Free cash flow margin: 16.11724636185365%
Revenue growth: -4.608910353831391%
Rule of 40 score: 11.508336008022258
Market cap: 321590144 (Small Cap ($300M-$2B))
Debt to equity: 0.0154
Free cash flow (dilution adjusted): 995918.3673469388
Operating income: -145535.7142857143
Net income: -3362372.448979592
Long score: 8 | Short score: 5
Recommendation: Long
Stock screener scorecard for 1079.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 288193760 (Micro Cap ($50M-$300M))
Debt to equity: 0.0278
Long score: 2 | Short score: 3
Recommendation: Neutral